Business Description
JW Life Science Corp
ISIN : KR7234080000
Compare
Compare
Traded in other countries / regions
234080.Korea IPO Date
2016-10-27Description
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.25 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 0.84 | |||||
| Interest Coverage | 15.77 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.34 | |||||
| Beneish M-Score | -3.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.8 | |||||
| 3-Year EBITDA Growth Rate | 12.2 | |||||
| 3-Year EPS without NRI Growth Rate | 8.1 | |||||
| 3-Year FCF Growth Rate | -0.6 | |||||
| 3-Year Book Growth Rate | 7.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.43 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.94 | |||||
| 9-Day RSI | 50.6 | |||||
| 14-Day RSI | 51.29 | |||||
| 6-1 Month Momentum % | -2.61 | |||||
| 12-1 Month Momentum % | -12.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | |||||
| Quick Ratio | 1.7 | |||||
| Cash Ratio | 0.94 | |||||
| Days Inventory | 52.67 | |||||
| Days Sales Outstanding | 86.67 | |||||
| Days Payable | 39.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.4 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| Forward Dividend Yield % | 4.4 | |||||
| 5-Year Yield-on-Cost % | 4.4 | |||||
| 3-Year Average Share Buyback Ratio | 0.7 | |||||
| Shareholder Yield % | 12.7 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.57 | |||||
| Operating Margin % | 15.48 | |||||
| Net Margin % | 13.02 | |||||
| FCF Margin % | 21.48 | |||||
| ROE % | 18 | |||||
| ROA % | 11.15 | |||||
| ROIC % | 14.08 | |||||
| ROC (Joel Greenblatt) % | 24.63 | |||||
| ROCE % | 21.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.11 | |||||
| Forward PE Ratio | 6.54 | |||||
| PE Ratio without NRI | 5.83 | |||||
| Shiller PE Ratio | 10.29 | |||||
| Price-to-Owner-Earnings | 3.43 | |||||
| PEG Ratio | 1.06 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 1.03 | |||||
| Price-to-Tangible-Book | 1.06 | |||||
| Price-to-Free-Cash-Flow | 3.7 | |||||
| Price-to-Operating-Cash-Flow | 3.13 | |||||
| EV-to-EBIT | 4.39 | |||||
| EV-to-EBITDA | 3.09 | |||||
| EV-to-Revenue | 0.75 | |||||
| EV-to-FCF | 3.47 | |||||
| Price-to-Projected-FCF | 0.45 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.94 | |||||
| Price-to-Graham-Number | 0.52 | |||||
| Price-to-Net-Current-Asset-Value | 5.44 | |||||
| Earnings Yield (Greenblatt) % | 22.78 | |||||
| FCF Yield % | 27 | |||||
| Forward Rate of Return (Yacktman) % | 20.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JW Life Science Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 221,320.741 | ||
| EPS (TTM) (â‚©) | 1861 | ||
| Beta | 0.51 | ||
| Volatility % | 13.35 | ||
| 14-Day RSI | 51.29 | ||
| 14-Day ATR (â‚©) | 244.048756 | ||
| 20-Day SMA (â‚©) | 11315 | ||
| 12-1 Month Momentum % | -12.35 | ||
| 52-Week Range (â‚©) | 10680 - 13550 | ||
| Shares Outstanding (Mil) | 15.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JW Life Science Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JW Life Science Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
JW Life Science Corp Frequently Asked Questions
What is JW Life Science Corp(XKRX:234080)'s stock price today?
The current price of XKRX:234080 is â‚©11370.00. The 52 week high of XKRX:234080 is â‚©13550.00 and 52 week low is â‚©10680.00.
When is next earnings date of JW Life Science Corp(XKRX:234080)?
The next earnings date of JW Life Science Corp(XKRX:234080) is .
Does JW Life Science Corp(XKRX:234080) pay dividends? If so, how much?
The Dividend Yield %  of JW Life Science Corp(XKRX:234080) is 4.4% (As of Today), Highest Dividend Payout Ratio of JW Life Science Corp(XKRX:234080) was 0.94. The lowest was 0.26. And the median was 0.42. The  Forward Dividend Yield % of JW Life Science Corp(XKRX:234080) is 4.4%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers